Comparative study between simvastatin and simvastatin/ezetimibe with equivalent cholesterol reduction: Same benefits?

被引：0
|
作者：
De Araujo, Daniel Branco [1 ,2 ]
Bertolami, Marcelo Chiara [1 ,2 ]
Ferreira, Waldinai Pereira [1 ,2 ]
Abdalla, Dulcineia Saes Parra [1 ,2 ]
Faludi, Andre Arpad [1 ,2 ]
Nakamura, Yara [1 ,2 ]
Bricarelo, Liliana Paula [1 ,2 ]
机构：
[1] Inst Dante Pazzanese Cardiol, Sao Paulo, SP, Brazil
[2] Inst Coracao, Sao Paulo, SP, Brazil
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(07)71968-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Pleiotropic Effects With Equivalent Low-density Lipoprotein Cholesterol Reduction: Comparative Study Between Simvastatin and Simvastatin/Ezetimibe Coadministration
    Araujo, Daniel B.
    Bertolami, Marcelo C.
    Ferreira, Waldinai P.
    Abdalla, Dulcineia S. P.
    Faludi, Andre A.
    Nakamura, Yara
    Bricharello, Liliana P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (01) : 1 - 5
  • [2] Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
    Farnier, Michel
    Guyton, John R.
    Jensen, Erin
    Polis, Adam B.
    Johnson-Levonas, Amy O.
    Brudi, Philippe
    ATHEROSCLEROSIS, 2013, 229 (02) : 415 - 422
  • [3] Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
    Farnier, M.
    Guyton, J. R.
    Jensen, E.
    Polis, A.
    Johnson-Levonas, A. O.
    Brudi, P.
    EUROPEAN HEART JOURNAL, 2012, 33 : 281 - 282
  • [4] Ezetimibe/simvastatin combination reduces LDL cholesterol
    不详
    FORMULARY, 2004, 39 (04) : 199 - 200
  • [5] Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin
    Lakoski, Susan G.
    Xu, Fang
    Vega, Gloria L.
    Grundy, Scott M.
    Chandalia, Manisha
    Lam, Chun
    Lowe, Robert S.
    Stepanavage, Michael E.
    Musliner, Thomas A.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 800 - 809
  • [6] Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin
    Kosoglou, T
    Meyer, I
    Veltri, EP
    Statkevich, P
    Yang, B
    Zhu, Y
    Mellars, L
    Maxwell, SE
    Patrick, JE
    Cutler, DL
    Batra, VK
    Affrime, MB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (03) : 309 - 319
  • [7] Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men
    Sudhop, Thomas
    Reber, Michael
    Tribble, Diane
    Sapre, Aditi
    Taggart, William
    Gibbons, Patrice
    Musliner, Thomas
    von Bergmann, Klaus
    Luetjohann, Dieter
    JOURNAL OF LIPID RESEARCH, 2009, 50 (10) : 2117 - 2123
  • [8] CHANGES IN THE INTESTINAL ABSORPTION OF PHYTOSTEROLS AND CHOLESTEROL BY EZETIMIBE AND/OR SIMVASTATIN IN MEN
    Taggart, W.
    Musliner, T.
    Reber, M.
    Sudhop, T.
    Sapre, A.
    von Bergmann, K.
    Luetjohann, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [9] REMNANT CHOLESTEROL REDUCTION BY EZETIMIBE AND SIMVASTATIN DOES NOT AFFECT BILIARY LIPID CONCENTRATION IN GALLSTONE PATIENTS
    Eriksson, M.
    Ahmed, O.
    Gustafsson, U.
    Littman, K.
    Sahlin, S.
    Pramfalk, C.
    Parini, P.
    ATHEROSCLEROSIS, 2016, 252 : E62 - E62
  • [10] Inhibition of intestinal cholesterol absorption and endogenous cholesterol synthesis by ezetimibe/simvastatin in humans
    Lütjohann, D
    Sudhop, T
    Reber, M
    Tribble, DL
    Gibbons, P
    Sapre, A
    von Bergmann, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 713 - 713
12345